SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-074096
Filing Date
2019-12-19
Accepted
2019-12-19 08:31:56
Documents
3
Period of Report
2019-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1926529d1_8k.htm 8-K 22426
2 EXHIBIT 99.1 tm1926529d1_ex99-1.htm EX-99.1 12099
3 GRAPHIC tm1926529d1_ex99-1img001.jpg GRAPHIC 4245
  Complete submission text file 0001104659-19-074096.txt   41846
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 191294195
SIC: 2834 Pharmaceutical Preparations